SRP-6004

· Sarepta Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SRP-6004, covering 2025-09-04 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: A Gene Transfer Study to Evaluate the Safety, Tolerability and Efficacy of SRP-6004 in Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2B/R2 (LGMD2B/R2, Dysferlin [DYSF] Related) [Phase 1]

See pricing